COSALDON RETARD Tablet Sydafrika - engelska - South African Health Products Regulatory Authority (SAHPRA)

cosaldon retard tablet

sanofi-aventis south africa (pty) ltd - tablet - each tablet contains nicotinic acid 100 mg pentifylline 400 mg

MINIRIN desmopressin acetate 200 microgram tablet bottle Australien - engelska - Department of Health (Therapeutic Goods Administration)

minirin desmopressin acetate 200 microgram tablet bottle

ferring pharmaceuticals pty ltd - desmopressin acetate, quantity: 0.2 mg (equivalent: desmopressin, qty 178 microgram) - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; povidone; potato starch - minirin tablets are indicated for the treatment of: cranial diabetes insipidus; primary nocturnal enuresis, in patients from 6 years of age with normal ability to concentrate urine, who are refractory to an enuresis alarm, or in whom an enuresis alarm is contraindicated or inappropriate.

MINIRIN desmopressin acetate 100 microgram tablet bottle Australien - engelska - Department of Health (Therapeutic Goods Administration)

minirin desmopressin acetate 100 microgram tablet bottle

ferring pharmaceuticals pty ltd - desmopressin acetate, quantity: 0.1 mg (equivalent: desmopressin, qty 89 microgram) - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; potato starch; povidone - minirin tablets are indicated for the treatment of: cranial diabetes insipidus; primary nocturnal enuresis, in patients from 6 years of age with normal ability to concentrate urine, who are refractory to an enuresis alarm, or in whom an enuresis alarm is contraindicated or inappropriate.

NAPROXEN tablet
EC-NAPROXEN- naproxen tablet, delayed release
NAPROXEN SODIUM DS- naproxen sodium tablet USA - engelska - NLM (National Library of Medicine)

naproxen tablet ec-naproxen- naproxen tablet, delayed release naproxen sodium ds- naproxen sodium tablet

woodward pharma services llc - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - naproxen tablets, ec-naproxen, and naproxen sodium are indicated for: the relief of the signs and symptoms of: - rheumatoid arthritis - osteoarthritis - ankylosing spondylitis - polyarticular juvenile idiopathic arthritis naproxen tablets and naproxen sodium are also indicated for: the relief of signs and symptoms of: - tendonitis - bursitis - acute gout the management of: - pain - primary dysmenorrhea naproxen tablets, ec-naproxen, and naproxen sodium are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to naproxen or any components of the drug product [see warnings and precautions (5.7, 5.9)]. - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7, 5.8)] . - in the setting of coronary artery bypass graft (cabg) surgery [see warnings and precautions (5.1)] .

MINIRIN TABLETS 0.1 MG Israel - engelska - Ministry of Health

minirin tablets 0.1 mg

ferring pharmaceuticals ltd - desmopressin acetate - tablets - desmopressin acetate 0.1 mg - desmopressin - desmopressin - central diabetes insipidus.nocturnal enuresis. treatment of nocturia in adults associated with nocturnal polyuria.

MINIRIN TABLETS 0.2 MG Israel - engelska - Ministry of Health

minirin tablets 0.2 mg

ferring pharmaceuticals ltd - desmopressin acetate - tablets - desmopressin acetate 0.2 mg - desmopressin - central diabetes insipidus.nocturnal enuresis. treatment of nocturia in adults associated with nocturnal polyuria.